EUVIMEDEUVIMED entdecken
Vergleichsstudie

Extracorporeal membrane oxygenation versus invasive ventilation in patients with COVID ‐19 acute respiratory distress syndrome and pneumomediastinum: A cohort trial

Rachid Attou iD, Sebastien Redant iD, Dimitrios Velissaris iD, Keitiane Kefer iD, Mazen Abou Lebdeh, Eric Waterplas, Charalampos Pierrakos iD

Artificial Organs · 2024

DOI: 10.1111/aor.14760 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Artificial Organs, 2024. Verfasst von Rachid Attou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care, Brugmann University Hospital, Université Libre de Bruxelles, Brussels, Belgium. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, COVID-19, Mediastinal Emphysema, Respiration, Artificial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with severe respiratory failure due to COVID‐19 who are not under mechanical ventilation may develop severe hypoxemia when complicated with spontaneous pneumomediastinum (PM). These patients may be harmed by invasive ventilation. Alternatively, veno‐venous (V‐V) extracorporeal membrane oxygenation (ECMO) may be applied. We report on the efficacy of V‐V ECMO and invasive ventilation as initial advanced respiratory support in patients with COVID‐19 and acute respiratory failure due to spontaneous PM.

Methods

This was a retrospective cohort study performed between March 2020 and January 2022. Enrolled patients had COVID‐19 and acute respiratory failure due to spontaneous PM and were not invasively ventilated. Patients were treated in the intensive care unit (ICU) with invasive ventilation (invasive ventilation group) or V‐V ECMO support (V‐V ECMO group) as the main therapeutic option. The primary outcomes were mortality and ICU discharge at 90 days after ICU admission.

Results

Twenty‐two patients were included in this study (invasive ventilation group: 13 [59%]; V‐V ECMO group: 9 [41%]). The V‐V ECMO strategy was significantly associated with lower mortality (hazard ratio [HR] 0.33 [95% CI 0.12–0.97], p = 0.04). Five (38%) patients in the V‐V ECMO group were intubated and eight (89%) patients in the invasive ventilation group required V‐V ECMO support within 30 days from ICU admission. Three (33%) patients in the V‐V ECMO group were discharged from ICU within 90 days compared to one (8%) patient in the invasive ventilation group (HR 4.71 [95% CI 0.48–45.3], p = 0.18).

Conclusions

Preliminary data suggest that V‐V ECMO without invasive ventilation may improve survival in COVID‐19‐related acute respiratory failure due to spontaneous PM. The study's retrospective design and limited sample size underscore the necessity for additional investigation and warrant caution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationCOVID-19Mediastinal EmphysemaRespiration, ArtificialRespiratory Distress SyndromeHumansMaleFemaleMiddle AgedRetrospective StudiesAgedIntensive Care UnitsAdultSARS-CoV-2Treatment Outcome

Stichwörter der Autor:innen

ARDSECMOartificial ventilationcoronavirus disease 2019mechanical ventilationmediastinal emphysemamortality

Autor:innen und Institutionen

  • Department of Intensive Care, Brugmann University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
  • Department of Internal Medicine, University Hospital of Patras, Patras, Greece.

ORCID-Profile: Rachid Attou, Sebastien Redant, Dimitrios Velissaris, Keitiane Kefer, Charalampos Pierrakos

Zitieren

APA

Attou, R., Redant, S., Velissaris, D., Kefer, K., Abou Lebdeh, M., Waterplas, E., & Pierrakos, C. (2024). Extracorporeal membrane oxygenation versus invasive ventilation in patients with COVID ‐19 acute respiratory distress syndrome and pneumomediastinum: A cohort trial. Artificial Organs. https://doi.org/10.1111/aor.14760

Vancouver

Attou R, Redant S, Velissaris D, Kefer K, Abou Lebdeh M, Waterplas E, et al. Extracorporeal membrane oxygenation versus invasive ventilation in patients with COVID ‐19 acute respiratory distress syndrome and pneumomediastinum: A cohort trial. Artificial Organs. 2024. doi:10.1111/aor.14760

BibTeX
@article{Attou2024,
  author = {Attou, Rachid and Redant, Sebastien and Velissaris, Dimitrios and Kefer, Keitiane and Abou Lebdeh, Mazen and Waterplas, Eric and Pierrakos, Charalampos},
  title = {Extracorporeal membrane oxygenation versus invasive ventilation in patients with COVID ‐19 acute respiratory distress syndrome and pneumomediastinum: A cohort trial},
  journal = {Artificial Organs},
  year = {2024},
  doi = {10.1111/aor.14760}
}
Kostenlos starten →